Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | LNK001 |
| Trade Name | |
| Synonyms | LNK 001|LNK-001 |
| Drug Descriptions |
Limited information is currently available on LNK001, a putative chimeric antigen receptor (CAR) T-cell therapy targeting CA9 (CAIX) and ENPP3 (Jun 2026). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| LNK001 | LNK001 | 0 | 1 |